Skip to main

Scheduled Maintenance Friday 1 May

Maintenance is scheduled between 9pm - 12 am AEST, Friday 1 May 2026 and the site may be unavailable or slow during this time.

Designation of Adalimumab (Humira) as an orphan drug - AbbVie Pty Ltd

Administered by
  • Department of Health, Disability and Ageing

This item is authorised by the following title:

Latest version
C2015G0134720 August 2015

Legislation text